_id
69130ed8ccc777a4e85d7dde
Ticker
LIPO
Name
Lipella Pharmaceuticals Inc. Common Stock
Exchange
NASDAQ
Address
7800 Susquehanna St., Pittsburgh, PA, United States, 15208
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://lipella.com
Description
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.
Last Close
0.171
Volume
225
Current Price
0.171
Change
0.0101
Last Updated
2026-01-04T16:33:40.359Z
Image
data:image/webp;base64,UklGRmoMAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSFoGAAABoL9t2/FGHtJ1P++bFGPbWtu2bdu2bdu2bdu2bavTbZtMev8wbdrsbERMAP/zkdKMFYLQDCTGrrpo6ixS/DcU6iSY8K19PupAgP4LIYiOMle7ZZoXIQFijl3nQ7UT/RcdioicydzpljYvT4SCdW3vTNQqWOgHN29CAhSs7opf7UFGpE/d5m97otoInnLZXw9kwVN3KBKsctVpg/MJnxwm6n9yq38cVLvG711qb5owttk+nZwhONxt3hFOcMmXUKDGwelu8wMc63/8ej0q5AKPu8lnEXmH23cuINVI9Djs5Uv7sXRlmq9i1CQI1nG7VycFYsmTlqO2kZMABRu+dnFhwV9atyPEkkcvgkSRNSvtXp9EhLpBAgmUUl1BguBB+8eMJMZcsCnK3Ou/fTEpQOqKAoWYdOa6SAARRQ607yIR9PvIXp8i+7vNB5A1ZdleqAtQn4PxP9r70P+480YiIG91yECkYOZyySdQoP7YN49NwSH2B5OJakThjB+eXoIDPNXvcZ79MElBiF4HLUkEh/jFIQgBidmmus2XVZc4xiV/VbeyS76eh+yPmV51XOp/xhFE7wwEMz308Mys7rY2PwHqTOJBl1q9IPu8fONwFnz/65U48IdNicTF/nM8IeYajiQetm+l1+suezsSVSYucsm/jyGERM/+DJnqtxsJeu+8EEps789GEOIx+zYYf93ruyKqFcMe+PeHdUg5kggpcUbpWILpReYmV5YjBfO8+PhEkkBBV2PmgShQIEVADA8ApQAx5q6j6FSi91k3LIi6IKGAEUOBnIBA01UfbHDPQmRxq/3jSFQdgsTW5eblmfTEfYMRompFEIz7xa8hBnztJm9Frk7MPT+8bD/EQfaGJLpR9HjG5xPBA/YfE4mqxFHtPpUr7ZNZ+PevxxPdgeg/Xz1K9D/nlsXJSVUEo8uueDaO2KMehg2muyVCFNZeGimDopMUjGmxyzMTiJDUXSgUnGDvToG5VxuBOhCNRfb8q+kQIqeUUgQ1zCl/Z78G+9o/zEt0cMj7L67I2LF0KmoogkPsrRjf6lY/NF1ia5f910QUKWcWe2IP1H1il6tGsNQCMKVSbvWLCILr3dbq7SkC4n57MtFdwTz2xSRSSo+55P1JkDjYJbfNS2bVk2blYD/biLpv1Dfen0KSGHzanTtKgOh5g6fuSGaJaf58GJP6UEMxZkkQvQ86fhJB0HFh8kiiyFZu9XKkUA06jOAm+7P+FOhYASHR/wlfiiJl1SJSBBN+Lbd4ZVInKALWPHBccY4CiBoqZ8S4vjxp/zQSdQaJfeyfx5IlVjiiF+ouEPuW3hk+5I5nFkFUKRredbN3JgWT//b1pG4RA84/gEFT230aCUTV4iaXvCwRjP/Zl3dT4kx7LT6yt6RI6tLwmz7cBUliyT0bUTft7L/mZNK5WyNlujS9RJ+d1xVCEdGFEKAlZ0Ugpjz828UNqIpg/puunZ0Q19q7khFdDaYLpCg0pOLLbvO5RGfBbE32r+Oh/zftvpoCdde8PJkARUeM7olSFCSRWMytJX/aE3WSOd2trT6MIkf6t0UpsLp9GhkJAYltWu6rRxBMvuHIwoCvXPItiE4T+7lc9pakYOJwJEa88deyBBRG0cG9bp7Moa/twYiv7atZ/ZvmlyYTnYnGp+2Hi4hl9hqKgN79SMBF3hcRLPPFOazhimdfxc2V74fTd0pGVN24wdoFJba3f5xEIOaak8TEJn9YTxKQWccVzz9kqn0vSSioWoJQ8LCbfBo5sbe9AZn9v1yLQAQhDn5rT1j69vMGIwVdVc6QuMolb0Om/k37ThJqYM77j2skRwgKkACJ7hYj7vjsKJKCE+x9ySno+Zl9MAmkxLjR5EiilqkIBGiNlRkxgKDvX/ap7P/hHaOIM/7+5whETRPj73n1kIQkDv/jm9XIbPH1w3WruuTb2djT2r0GqRai8T2XfCApsYwr/qRBQTGzl5v8Hoe7tcUHUahFsGCl3OaniMw6LvmLPtTXU2Tiz/ZhrOyK25cg1WZCs8u+gQTcah/A+m++vyWJKYetS7DjN59sgahpsGPZ7w9HQF5mXuYvud2rkJhe1BURNRajF+xDh0HiCLe2+EZyFBIQENQ8IKIDUoGVXal4BxIdS/wHFaLaE1v+PV+okxlQmjRJwQysBKEZCSL4vwdWUDgg6gUAAHAYAJ0BKkAAQAA+mTqTSaWjIaE5/YqosBMJbAC2+w5A1JAqn928gHS90B5pPN3OA8wDnAeYDzuPQB6AH7Jesb6gHoAfsB6cvsK/uv+4ftZdQBwDvar32+TYC8YoaDLM+w3QP/rvCg+q+WH0VM2P1n7APlk+ub9ofYp/YZnw2B/u+O4OWbWtWs3n10hfTzgMP5jhHCa9Cjvl1zmsBSftVaOogzqVBB5vQZhrRIPkyuYjrD9ykwrDzJnVcQyS5+PNmGEHkGYr/JK74oBRAAD+92wURFoMdYT6IptUCfQHB+8TXRGcnIU5uNAwVePkxUwxSDOY9g99pSWIgXIaSvdBMXSJS1Rx5pfDg3aQ2xsWyiPToPxUzOryULr0oggiMvlD/oByXtffBCB/FH9z15HhEB2WTMD3sRkX1OvOnh+qW4JF1u0v8kWm0sKPRugJ0g/E8gigLg6Xbj8F6qqQeu5gjFESaR/QCY+SVT7YaVlmh87wIyDdOeudiRqutH3g5rARfEnzhs2EaMtZ1ovPtZ4HCmz89oWZoiHGspoGEv/dD57T1P2mOuwtYIALN8/dKFMubAC99QYoP1lv/BVRQeBJDhP/4KC/xQfVgiioPiyfYAZA10pHj/0+jK6/TXWOV3j0Tro7S8+XSoHDELJfjgK8VHNMrKWPhsIQ8v6RXc66TGrHzzERT50PaJ7mtmplTwFYHO6VF24ZQKCOZIfTLd1DHh/urem85aJDJgkRHVeBmJW6DgOyGGDUMwDM8ype81ucNEojQ2lLBwWeCJclYzTF9a/LD7vID/0NhBgGOdZFno83lIKAhCb21v5WFgQu7/s8bpO5q9Afg1qeSThYj2Oi+Xt6FmANQbmxR7WutRd3z1azX6AHUga+D5RnJljDtp2P1UIN5qrTd/qvNkq7S80BmDlZH8KUf6TQfvxdBXS5xhO65CxPCv5PHT+ECUKgviBX08XgkNGCqutVltU0DA46SrgggKFa7D25rl00Q1NZM43VaQ7XBWe8G6oFo49dnuD23XEVoWb+oc9kLyAtelJXaLbBUiF9vM3U/hCoec0CiufgoHNoQm+VpV+os+PEnRy9htRMyxeH+inH9wFbpnvWScH+ZUBHlrqMef/VcQ8nUDrsFezuAJfq/xiCJzBir/H1PfrZl9SIeilyjqD6yMldxGJVRpIeqxJM+ab9rkQxPSwCFBu8XjbVvVdAAlApQs+j5TXwPX9R2PVWvV908JO9K1R48O6STXqg1w8UpHe/ZOeCKatZ8cB5RINc01oK79/l+wxDu1PKo22zc+/OUJ2nCB/KhB0g0iKxewnfeKUOcOtDTkFpI23XAIAaXxo5kqRQYtfCfSt2qne/clGBmRcmOTxE1xbFaa0CBY3sjYo7tyoKPyeHH8ZY2bLpoCqHm3VR3+ut0px0GSrqVBuJ4BMwfVBwGZQFUxoBtue3BO8td+ZBb4fMUKQlGPnKBtH+h+/W6iv5W1VAON9dzTriRu7hpMicRB4DVLGdLn9KnBDwEudRscOU3Fe89oX2Vnmc2H6s1xT31iuaHw0qOLqzUBtu9+OAI84Mm0YiRn0knajVVWXDEscMbY2Nn1TpjhsuUZNSrtoAxTtkym3amd0TvNfuoP5W0rMTSmdR+A0S7hHiAx5gu7hSzlse88QXLD5xgjKzvBywn6+j143O3hQvc8PhHt2+FKPALt9oHE6QR6OTRxgEY5t9HSuvddCh+PpUE0fAyUEzePGYsyRZSYx2vrb3Cc3Iz5ouZk3mscGoWdUnj3Fp+jC97qzfB+D+vXrUsZ/NQoV7B2j9SIbUiqc4238Uv96T8CP8cIHZhYRwgdUucs7UsP6MjW6zscky7JhRL/ajjSzHVMUQwiYUG9HhQrfl2Ua5I0MbIZ+8kSITLkQsNo6wI14SD1YOepBt/C+bRCpnisCDfi0/6ZWSUnpZC3z89gCTE04NYvz+6Ab2GFv5a+XaCfOlzs+CfnkvO6hAIW3Jyvf/O0cezzxFz1X0MbfGwfNfaMV8hLglwAAA
Ipo Date
2022-12-19T00:00:00.000Z
Market Cap
2449044
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
10
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
720973
Gross Profit
-720973
Operating Expenses
1274272000
Operating Income
-1274272000
Interest Expense
-
Pretax Income
-1254078000
Net Income
-1254078000
Eps
-275.6748557962859
Dividends Per Share
-
Shares Outstanding
4620837
Income Tax Expense
-
EBITDA
-1251914443
Operating Margin
-
Total Other Income Expense Net
20194000
Cash
1855771000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
2079288000
Property Plant Equipment
262823000
Total Assets
2349810000
Payables
462892000
Short Term Debt
44267000
Long Term Debt
-
Total Liabilities
862215000
Equity
1487595000
Bs_currency_symbol
USD
Depreciation
2163557
Change In Working Capital
226697
Cash From Operations
-2357761862
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
4210750035
Net Change In Cash
1852988173
Cf_currency_symbol
USD
PE
-
PB
0.0005229242636604722
ROE
-84.30238068829217
ROA
-53.36933624420698
FCF
-2357761862
Fcf Percent
-
Piotroski FScore
0
Health Score
37
Deep Value Investing Score
6.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
5.5
Net Net Investing Score
8
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
720973
Quarters > 0 > income Statement > gross Profit
-720973
Quarters > 0 > income Statement > operating Expenses
1274272000
Quarters > 0 > income Statement > operating Income
-1274272000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1254078000
Quarters > 0 > income Statement > net Income
-1254078000
Quarters > 0 > income Statement > eps
-275.6748557962859
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4549120
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1251914443
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
20194000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1855771000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2079288000
Quarters > 0 > balance Sheet > property Plant Equipment
262823000
Quarters > 0 > balance Sheet > total Assets
2349810000
Quarters > 0 > balance Sheet > payables
462892000
Quarters > 0 > balance Sheet > short Term Debt
44267000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
862215000
Quarters > 0 > balance Sheet > equity
1487595000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3885452991
Quarters > 0 > cash Flow > depreciation
2163557
Quarters > 0 > cash Flow > change In Working Capital
226697
Quarters > 0 > cash Flow > cash From Operations
-2357761862
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
4210750035
Quarters > 0 > cash Flow > net Change In Cash
1852988173
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-275.6748557962859
Quarters > 0 > ratios > PB
0.0005229242636604722
Quarters > 0 > ratios > ROE
-84.30238068829217
Quarters > 0 > ratios > ROA
-53.36933624420698
Quarters > 0 > ratios > FCF
-2357761862
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
86727000
Quarters > 1 > income Statement > cost Of Revenue
791581
Quarters > 1 > income Statement > gross Profit
-791581
Quarters > 1 > income Statement > operating Expenses
564994
Quarters > 1 > income Statement > operating Income
-1356575
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1327486
Quarters > 1 > income Statement > net Income
-1327486
Quarters > 1 > income Statement > eps
-0.3083417126512952
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4305243
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1355854
Quarters > 1 > income Statement > operating Margin
-1.564189929318436
Quarters > 1 > income Statement > total Other Income Expense Net
29089
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2781828
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
41982
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3437246
Quarters > 1 > balance Sheet > property Plant Equipment
282960
Quarters > 1 > balance Sheet > total Assets
3720206
Quarters > 1 > balance Sheet > payables
608110
Quarters > 1 > balance Sheet > short Term Debt
42945903
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
978534
Quarters > 1 > balance Sheet > equity
2741672
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1327486
Quarters > 1 > cash Flow > depreciation
721
Quarters > 1 > cash Flow > change In Working Capital
-106372
Quarters > 1 > cash Flow > cash From Operations
-1433138
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-10047
Quarters > 1 > cash Flow > net Change In Cash
-1443185
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.3083417126512952
Quarters > 1 > ratios > PB
0.2685210167372319
Quarters > 1 > ratios > ROE
-48.418848060599515
Quarters > 1 > ratios > ROA
-35.683131525512295
Quarters > 1 > ratios > FCF
-1433138
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.016524703956092106
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
129390000
Quarters > 2 > income Statement > cost Of Revenue
993475
Quarters > 2 > income Statement > gross Profit
-993475
Quarters > 2 > income Statement > operating Expenses
334346
Quarters > 2 > income Statement > operating Income
-1327821
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1306523
Quarters > 2 > income Statement > net Income
-1306523
Quarters > 2 > income Statement > eps
-1.24646221802449
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1048185
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1305801
Quarters > 2 > income Statement > operating Margin
-1.026216090888013
Quarters > 2 > income Statement > total Other Income Expense Net
21298
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
4225012
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
85630
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4823337
Quarters > 2 > balance Sheet > property Plant Equipment
32714
Quarters > 2 > balance Sheet > total Assets
4856051
Quarters > 2 > balance Sheet > payables
392115
Quarters > 2 > balance Sheet > short Term Debt
23997
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
776847
Quarters > 2 > balance Sheet > equity
4079204
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1306523
Quarters > 2 > cash Flow > depreciation
722
Quarters > 2 > cash Flow > change In Working Capital
-120325
Quarters > 2 > cash Flow > cash From Operations
-1426126
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
3466275
Quarters > 2 > cash Flow > net Change In Cash
2040149
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.24646221802449
Quarters > 2 > ratios > PB
0.04393985566791953
Quarters > 2 > ratios > ROE
-32.02887131901224
Quarters > 2 > ratios > ROA
-26.90505103838489
Quarters > 2 > ratios > FCF
-1426126
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.011021918231702605
Quarters > 2 > health Score
33
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
173666
Quarters > 3 > income Statement > cost Of Revenue
1062336
Quarters > 3 > income Statement > gross Profit
-888670
Quarters > 3 > income Statement > operating Expenses
562622
Quarters > 3 > income Statement > operating Income
-1451292
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-1441672
Quarters > 3 > income Statement > net Income
-1441672
Quarters > 3 > income Statement > eps
-1.3753984268044286
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1048185
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1440951
Quarters > 3 > income Statement > operating Margin
-835.6799834164431
Quarters > 3 > income Statement > total Other Income Expense Net
9620
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2184863
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
84713
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2617252
Quarters > 3 > balance Sheet > property Plant Equipment
56618
Quarters > 3 > balance Sheet > total Assets
2673870
Quarters > 3 > balance Sheet > payables
388191
Quarters > 3 > balance Sheet > short Term Debt
47605
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
754417
Quarters > 3 > balance Sheet > equity
1919453
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1441672
Quarters > 3 > cash Flow > depreciation
721
Quarters > 3 > cash Flow > change In Working Capital
369869
Quarters > 3 > cash Flow > cash From Operations
-990413
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1821540
Quarters > 3 > cash Flow > net Change In Cash
831129
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.3753984268044286
Quarters > 3 > ratios > PB
0.09338058030074194
Quarters > 3 > ratios > ROE
-75.1084814267398
Quarters > 3 > ratios > ROA
-53.91705655099164
Quarters > 3 > ratios > FCF
-990413
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.702975827162485
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
536357
Annuals > 0 > income Statement > cost Of Revenue
3613187
Annuals > 0 > income Statement > gross Profit
-3076830
Annuals > 0 > income Statement > operating Expenses
2003712
Annuals > 0 > income Statement > operating Income
-5080542
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-5016264
Annuals > 0 > income Statement > net Income
-5016264
Annuals > 0 > income Statement > eps
-4.785671218030422
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1048184
Annuals > 0 > income Statement > income Tax Expense
-5016264000
Annuals > 0 > income Statement > EBITDA
-5013378
Annuals > 0 > income Statement > operating Margin
-947.2314148971673
Annuals > 0 > income Statement > total Other Income Expense Net
64278
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2184863
Annuals > 0 > balance Sheet > short Term Investments
2182678137
Annuals > 0 > balance Sheet > receivables
84713
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2617252
Annuals > 0 > balance Sheet > property Plant Equipment
56618
Annuals > 0 > balance Sheet > total Assets
2673870
Annuals > 0 > balance Sheet > payables
388191
Annuals > 0 > balance Sheet > short Term Debt
47605
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
754417
Annuals > 0 > balance Sheet > equity
1919453
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-5016264
Annuals > 0 > cash Flow > depreciation
2886
Annuals > 0 > cash Flow > change In Working Capital
113235
Annuals > 0 > cash Flow > cash From Operations
-3950747
Annuals > 0 > cash Flow > capital Expenditures
3
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
2841872
Annuals > 0 > cash Flow > net Change In Cash
-1108875
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.785671218030422
Annuals > 0 > ratios > PB
0.103810709822017
Annuals > 0 > ratios > ROE
-261.33820416545757
Annuals > 0 > ratios > ROA
-187.60313702610821
Annuals > 0 > ratios > FCF
-3950750
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-7.365896222105799
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
449617
Annuals > 1 > income Statement > cost Of Revenue
3038836
Annuals > 1 > income Statement > gross Profit
-2589219
Annuals > 1 > income Statement > operating Expenses
2156734
Annuals > 1 > income Statement > operating Income
-4745953
Annuals > 1 > income Statement > interest Expense
10848
Annuals > 1 > income Statement > pretax Income
-4618965
Annuals > 1 > income Statement > net Income
-4618965
Annuals > 1 > income Statement > eps
-6.1554684001791085
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
750384
Annuals > 1 > income Statement > income Tax Expense
5
Annuals > 1 > income Statement > EBITDA
-4606432
Annuals > 1 > income Statement > operating Margin
-1055.554616484697
Annuals > 1 > income Statement > total Other Income Expense Net
126988
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3293738
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
32286
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3429280
Annuals > 1 > balance Sheet > property Plant Equipment
147894
Annuals > 1 > balance Sheet > total Assets
3577174
Annuals > 1 > balance Sheet > payables
138016
Annuals > 1 > balance Sheet > short Term Debt
89223
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
432726
Annuals > 1 > balance Sheet > equity
3144448
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4618965
Annuals > 1 > cash Flow > depreciation
1685
Annuals > 1 > cash Flow > change In Working Capital
-9108
Annuals > 1 > cash Flow > cash From Operations
-3150172
Annuals > 1 > cash Flow > capital Expenditures
14434
Annuals > 1 > cash Flow > cash From Investing
-14434
Annuals > 1 > cash Flow > cash From Financing
1336601
Annuals > 1 > cash Flow > net Change In Cash
-1828005
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-6.1554684001791085
Annuals > 1 > ratios > PB
0.04536503653423431
Annuals > 1 > ratios > ROE
-146.89271376088902
Annuals > 1 > ratios > ROA
-129.12329677002012
Annuals > 1 > ratios > FCF
-3164606
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-7.0384482793132825
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
184156
Annuals > 2 > income Statement > cost Of Revenue
2547677
Annuals > 2 > income Statement > gross Profit
-2363521
Annuals > 2 > income Statement > operating Expenses
226192
Annuals > 2 > income Statement > operating Income
-2589713
Annuals > 2 > income Statement > interest Expense
9612
Annuals > 2 > income Statement > pretax Income
-2597692
Annuals > 2 > income Statement > net Income
-2597692
Annuals > 2 > income Statement > eps
-5.117818345160744
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
507578
Annuals > 2 > income Statement > income Tax Expense
-1633
Annuals > 2 > income Statement > EBITDA
-2588080
Annuals > 2 > income Statement > operating Margin
-1406.2604530941157
Annuals > 2 > income Statement > total Other Income Expense Net
-7979
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5121743
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
113655
Annuals > 2 > balance Sheet > inventories
-113655
Annuals > 2 > balance Sheet > total Current Assets
5799289
Annuals > 2 > balance Sheet > property Plant Equipment
150821
Annuals > 2 > balance Sheet > total Assets
5950110
Annuals > 2 > balance Sheet > payables
384357
Annuals > 2 > balance Sheet > short Term Debt
333262
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1274514
Annuals > 2 > balance Sheet > equity
4675596
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2597692
Annuals > 2 > cash Flow > depreciation
0
Annuals > 2 > cash Flow > change In Working Capital
9523
Annuals > 2 > cash Flow > cash From Operations
-1831161
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
300546
Annuals > 2 > cash Flow > cash From Financing
5238530
Annuals > 2 > cash Flow > net Change In Cash
3707915
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-5.117818345160744
Annuals > 2 > ratios > PB
0.020637064836226224
Annuals > 2 > ratios > ROE
-55.5585213093689
Annuals > 2 > ratios > ROA
-43.657881955123514
Annuals > 2 > ratios > FCF
-1831161
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-9.943531571059319
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
259347
Annuals > 3 > income Statement > cost Of Revenue
1456791
Annuals > 3 > income Statement > gross Profit
-1197444
Annuals > 3 > income Statement > operating Expenses
718384
Annuals > 3 > income Statement > operating Income
-1915828
Annuals > 3 > income Statement > interest Expense
6834
Annuals > 3 > income Statement > pretax Income
-1865473
Annuals > 3 > income Statement > net Income
-1865473
Annuals > 3 > income Statement > eps
-4.37898292512312
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
426006
Annuals > 3 > income Statement > income Tax Expense
6730
Annuals > 3 > income Statement > EBITDA
-1858639
Annuals > 3 > income Statement > operating Margin
-738.7122272476644
Annuals > 3 > income Statement > total Other Income Expense Net
50355
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1413828
Annuals > 3 > balance Sheet > short Term Investments
300546
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1808089
Annuals > 3 > balance Sheet > property Plant Equipment
204800
Annuals > 3 > balance Sheet > total Assets
2012889
Annuals > 3 > balance Sheet > payables
46900
Annuals > 3 > balance Sheet > short Term Debt
64598
Annuals > 3 > balance Sheet > long Term Debt
50000
Annuals > 3 > balance Sheet > total Liabilities
589337
Annuals > 3 > balance Sheet > equity
1423552
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1865473
Annuals > 3 > cash Flow > depreciation
1915828
Annuals > 3 > cash Flow > change In Working Capital
197609
Annuals > 3 > cash Flow > cash From Operations
-989271
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-300546
Annuals > 3 > cash Flow > cash From Financing
2096909
Annuals > 3 > cash Flow > net Change In Cash
807092
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-4.37898292512312
Annuals > 3 > ratios > PB
0.05688850186013577
Annuals > 3 > ratios > ROE
-131.0435445983006
Annuals > 3 > ratios > ROA
-92.67639695979261
Annuals > 3 > ratios > FCF
-989271
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-3.814468646253861
Annuals > 3 > health Score
34
Valuation > metrics > PE
-275.6748557962859
Valuation > metrics > PB
0.0005229242636604722
Valuation > final Score
70
Valuation > verdict
99.9% Undervalued
Profitability > metrics > ROE
-84.30238068829217
Profitability > metrics > ROA
-60.31285709338966
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5796033194518669
Risk > metrics > Interest Coverage
-588.9708475441137
Risk > final Score
-2308
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.0998740040105766
Liquidity > metrics > Quick Ratio
4.0998740040105766
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-131
Prev Risks > 1
-7296
Prev Risks > 2
-7992
Prev Liquidities > 0
14
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:08:35.900Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-03
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.28
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.28
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-03
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.31
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.31
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-28
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.64
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-28
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.19
Earnings History > 4 > eps Estimate
-2.43
Earnings History > 4 > eps Difference
1.24
Earnings History > 4 > surprise Percent
51.0288
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-14
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.29
Earnings History > 5 > eps Estimate
-0.96
Earnings History > 5 > eps Difference
-0.33
Earnings History > 5 > surprise Percent
-34.375
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.96
Earnings History > 6 > eps Estimate
-1.04
Earnings History > 6 > eps Difference
0.08
Earnings History > 6 > surprise Percent
7.6923
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1634
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.8
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.8403
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-2.143
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-12
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.19
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-31
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.09
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-12-21
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.39
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.39
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-07-29
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.07
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.07
Earnings History > 14 > surprise Percent
-
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Opening: Is AMAL impacted by rising rates - July 2025 Sentiment & Low Risk High Reward Ideas baoquankhu1.vn
Read more →Aug Momentum: Will NINE benefit from rate cuts - July 2025 Drop Watch & Low Risk Profit Maximizing Plans baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$10
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.26% of the total shares of Lipella Pharmaceuticals Inc. Common Stock
1.
Fidelity Extended Market Index(0.1293%)
since
2025/05/31
2.
Vanguard Institutional Extnd Mkt Idx Tr(0.0966%)
since
2025/05/31
3.
Fidelity Series Total Market Index(0.03%)
since
2025/05/31
4.
Tower Research Capital LLC(0%)
since
2025/06/30
5.
Mccormack Advisors International(0%)
since
2025/06/30
6.
Virtu Financial LLC(0%)
since
2025/03/31
7.
Bank of America Corp(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0
Date
2025-09-30
EPS Actual
-0.28
EPS Estimate
0
EPS Difference
-0.28
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.